Diploma PLC (LON:DPLM – Get Free Report) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 3,627.05 ($46.01) and traded as high as GBX 4,138 ($52.49). Diploma shares last traded at GBX 4,098 ($51.99), with a volume of 175,608 shares changing hands.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the company. Berenberg Bank boosted their price objective on Diploma from GBX 4,400 ($55.82) to GBX 4,700 ($59.62) and gave the company a “buy” rating in a report on Monday, May 13th. Barclays reaffirmed an “overweight” rating and set a GBX 4,050 ($51.38) target price on shares of Diploma in a research report on Wednesday, May 15th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 4,500 ($57.08) target price on shares of Diploma in a research report on Tuesday, May 7th. Finally, Shore Capital reissued a “buy” rating on shares of Diploma in a research report on Monday, May 13th. One research analyst has rated the stock with a sell rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, Diploma has a consensus rating of “Moderate Buy” and an average price target of GBX 3,950 ($50.11).
Get Our Latest Stock Analysis on Diploma
Diploma Stock Up 0.5 %
Diploma Cuts Dividend
The firm also recently announced a dividend, which was paid on Friday, June 7th. Investors of record on Thursday, May 23rd were given a dividend of GBX 17.30 ($0.22) per share. This represents a yield of 0.44%. The ex-dividend date was Thursday, May 23rd. Diploma’s dividend payout ratio is currently 6,705.88%.
About Diploma
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
- Five stocks we like better than Diploma
- How to Use the MarketBeat Dividend Calculator
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- How Technical Indicators Can Help You Find Oversold Stocks
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- What is the Dow Jones Industrial Average (DJIA)?
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.